JP2024013088A - Liquid composition for oral cavity - Google Patents
Liquid composition for oral cavity Download PDFInfo
- Publication number
- JP2024013088A JP2024013088A JP2022115018A JP2022115018A JP2024013088A JP 2024013088 A JP2024013088 A JP 2024013088A JP 2022115018 A JP2022115018 A JP 2022115018A JP 2022115018 A JP2022115018 A JP 2022115018A JP 2024013088 A JP2024013088 A JP 2024013088A
- Authority
- JP
- Japan
- Prior art keywords
- liquid oral
- mass
- oral composition
- aluminum
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 103
- 239000007788 liquid Substances 0.000 title claims abstract description 96
- 210000000214 mouth Anatomy 0.000 title claims abstract description 34
- 238000004040 coloring Methods 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 30
- 150000001879 copper Chemical class 0.000 claims abstract description 22
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 18
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 18
- 238000005259 measurement Methods 0.000 claims abstract description 18
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 18
- 229920002258 tannic acid Polymers 0.000 claims abstract description 18
- 229940033123 tannic acid Drugs 0.000 claims abstract description 18
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 18
- 239000003112 inhibitor Substances 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 17
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims abstract description 16
- 229940108925 copper gluconate Drugs 0.000 claims abstract description 16
- 239000002244 precipitate Substances 0.000 claims abstract description 16
- 239000007864 aqueous solution Substances 0.000 claims abstract description 14
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 23
- 229910052802 copper Inorganic materials 0.000 claims description 12
- 239000010949 copper Substances 0.000 claims description 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 11
- 239000002324 mouth wash Substances 0.000 claims description 9
- POJWUDADGALRAB-UHFFFAOYSA-N allantion Natural products NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 claims description 8
- 229940051866 mouthwash Drugs 0.000 claims description 7
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 5
- 229960000458 allantoin Drugs 0.000 claims description 5
- 208000004509 Tooth Discoloration Diseases 0.000 claims description 4
- 206010044032 Tooth discolouration Diseases 0.000 claims description 4
- CSJKPFQJIDMSGF-UHFFFAOYSA-K aluminum;tribenzoate Chemical compound [Al+3].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 CSJKPFQJIDMSGF-UHFFFAOYSA-K 0.000 claims description 4
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 4
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 4
- 210000002200 mouth mucosa Anatomy 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 230000036367 tooth discoloration Effects 0.000 claims description 4
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 claims description 3
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 3
- 229930002875 chlorophyll Natural products 0.000 claims description 3
- 235000019804 chlorophyll Nutrition 0.000 claims description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 3
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 claims description 3
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 claims description 3
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 3
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 claims description 3
- 229940079841 sodium copper chlorophyllin Drugs 0.000 claims description 3
- 238000002845 discoloration Methods 0.000 abstract description 4
- 230000001629 suppression Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 23
- -1 inorganic acid salts Chemical class 0.000 description 22
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 13
- 235000002639 sodium chloride Nutrition 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 229960003511 macrogol Drugs 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229940099898 chlorophyllin Drugs 0.000 description 4
- 235000019805 chlorophyllin Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 3
- 208000032139 Halitosis Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 208000025371 Taste disease Diseases 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000019656 metallic taste Nutrition 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000019830 sodium polyphosphate Nutrition 0.000 description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 208000006558 Dental Calculus Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- ZUGAOYSWHHGDJY-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-aluminabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Al+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZUGAOYSWHHGDJY-UHFFFAOYSA-K 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CTEMZTQLPNKNKP-REGJXUDFSA-N Maltosyl trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 CTEMZTQLPNKNKP-REGJXUDFSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 description 1
- 206010030996 Oral mucosal discolouration Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 206010043949 Tongue discolouration Diseases 0.000 description 1
- 208000008617 Tooth Demineralization Diseases 0.000 description 1
- 206010072665 Tooth demineralisation Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940034794 benzylparaben Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- SPPIIOPGDLITJE-VLQRKCJKSA-N diazanium;(2s,3s,4s,5r,6s)-6-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-5-[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3,4-dihy Chemical compound N.N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O SPPIIOPGDLITJE-VLQRKCJKSA-N 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- QYIXCDOBOSTCEI-FBVYSKEZSA-N epidihydrocholesterin Chemical compound C([C@@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-FBVYSKEZSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000009627 gardenia yellow Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940113094 isopropylparaben Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229940073475 lysozyme hydrochloride Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- AXCXHFKZHDEKTP-UHFFFAOYSA-N para-methoxycinnamaldehyde Natural products COC1=CC=C(C=CC=O)C=C1 AXCXHFKZHDEKTP-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- YHLBDCUXFZRLFT-UHFFFAOYSA-N propane-1,1-diol;propane-1,3-diol Chemical compound CCC(O)O.OCCCO YHLBDCUXFZRLFT-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- DGPIGKCOQYBCJH-UHFFFAOYSA-M sodium;acetic acid;hydroxide Chemical compound O.[Na+].CC([O-])=O DGPIGKCOQYBCJH-UHFFFAOYSA-M 0.000 description 1
- YPSURXWRBACOSE-UHFFFAOYSA-M sodium;azulene-1-sulfonate;hydrate Chemical compound O.[Na+].C1=CC=CC=C2C(S(=O)(=O)[O-])=CC=C21 YPSURXWRBACOSE-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000057 synthetic resin Chemical group 0.000 description 1
- 229920003002 synthetic resin Chemical group 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、液体口腔用組成物に関する。 FIELD OF THE INVENTION The present invention relates to liquid oral compositions.
口腔用の製剤に銅化合物を配合する技術として、特許文献1(特開平11-269073号公報)および特許文献2(特開2021-91654号公報)に記載のものがある。 Techniques for blending copper compounds into oral preparations include those described in Patent Document 1 (Japanese Patent Application Laid-Open No. 11-269073) and Patent Document 2 (Japanese Patent Application Laid-Open No. 2021-91654).
特許文献1には、銅クロロフィリンの塩及び酸を含有してなる製剤(請求項1)、ならびに、酸を添加して銅クロロフィリンの塩による舌の着色を防止する方法(請求項7)について記載されている。また、同文献には、銅クロロフィリンカリウム及びクエン酸を配合した顆粒剤(実施例1)、ならびに、銅クロロフィリンカリウム及びクエン酸を配合したチュアブル錠について、舌の着色の度合いを観察したことが記載されている(表1等)。 Patent Document 1 describes a preparation containing a salt of copper chlorophyllin and an acid (claim 1), and a method of adding an acid to prevent tongue coloring due to the salt of copper chlorophyllin (claim 7). has been done. The same document also describes that the degree of tongue coloring was observed for granules containing copper chlorophyllin potassium and citric acid (Example 1) and chewable tablets containing copper chlorophyllin potassium and citric acid. (Table 1, etc.)
特許文献2には、水溶性多価金属塩が配合され、歯ブラシに載せ易く成形性に優れ、かつ保存後も収容容器からの排出性に優れる歯磨剤組成物に関する技術として(段落0001)、水溶性アルミニウム塩、水溶性銅塩及び水溶性亜鉛塩から選ばれる1種以上の水溶性多価金属塩、キサンタンガム及びカチオン性高分子化合物を含有する歯磨剤組成物について記載されている(請求項1)。 Patent Document 2 describes a technology related to a dentifrice composition that contains a water-soluble polyvalent metal salt, is easy to put on a toothbrush, has excellent moldability, and is easily discharged from a storage container even after storage (paragraph 0001). A dentifrice composition containing one or more water-soluble polyvalent metal salts selected from polyvalent aluminum salts, water-soluble copper salts, and water-soluble zinc salts, xanthan gum, and a cationic polymer compound is described (Claim 1). ).
一方、本発明者らは、液体口腔用組成物中にグルコン酸銅等の水溶性銅塩を配合すると、口腔内に、たとえば舌、口腔粘膜または歯に着色が生じる場合があることを見出した。 On the other hand, the present inventors have found that when a water-soluble copper salt such as copper gluconate is blended into a liquid oral composition, discoloration may occur in the oral cavity, for example, on the tongue, oral mucosa, or teeth. .
そこで、本発明は、水溶性銅塩が含まれる液体口腔用組成物を適用する際の口腔内の着色を抑制する技術を提供する。 Therefore, the present invention provides a technique for suppressing coloring in the oral cavity when applying a liquid oral composition containing a water-soluble copper salt.
本発明者らは、水溶性銅塩が含まれる液体口腔用組成物を使用した際の着色の原因を鋭意検討した。その結果、液体口腔用組成物中の水溶性銅塩と口腔内に存在する成分との反応が原因の一つとして見出された。たとえば、水溶性銅塩と、お茶に含まれるポリフェノール(たとえばタンニン酸)とが共存すると褐色の沈澱を生じることがあることが明らかになった。 The present inventors have intensively investigated the cause of coloration when using a liquid oral composition containing a water-soluble copper salt. As a result, one of the causes was found to be a reaction between the water-soluble copper salt in the liquid oral composition and components present in the oral cavity. For example, it has been revealed that the coexistence of water-soluble copper salts and polyphenols (such as tannic acid) contained in tea can result in brown precipitates.
そこで、本発明者らは、液体口腔用組成物中の水溶性銅塩と口腔内に存在する成分とによる着色を抑制すべくさらに検討を進めたところ、液体口腔用組成物の色特性を制御することが効果的であることを新たに見出し、本発明を完成させた。 Therefore, the present inventors conducted further studies to suppress the coloring caused by the water-soluble copper salt in the liquid oral composition and the components present in the oral cavity, and found that the color characteristics of the liquid oral composition could be controlled. We have newly discovered that it is effective to do this, and have completed the present invention.
本発明によれば、以下の液体口腔用組成物および歯着色抑制方法が提供される。
[1] (a)水溶性銅塩、および
(b)着色抑制剤
を含む液体口腔用組成物であって、
以下の方法で測定される色差ΔE*が10以上である、液体口腔用組成物。
(方法)
1.30mLの当該液体口腔用組成物に、タンニン酸の0.8質量%水溶液10mLを添加し、タンニン酸の最終濃度0.2質量%の測定溶液を調製する。
2.前記測定溶液を37℃にて1週間静置する。
3.静置後、室温、3000rpmで10分間遠心分離し、上清を除去して沈殿を回収する。沈殿の色を分光色彩計で測定し、CIE1976L*a*b*表色系で規定される測色値(L2*,a2*,b2*)を得る。
4.0.1質量%グルコン酸銅水溶液を対照として、上記1.~3.の手順でCIE1976L*a*b*表色系で規定される測色値(L1*,a1*,b1*)を得る。
5.以下の式(I)より色差ΔE*を算出する。
ΔE*=((L2*-L1*)2+(a2*-a1*)2+(b2*-b1*)2)1/2 (I)
[2] 25℃におけるpHが3.5以上8以下である、[1]に記載の液体口腔用組成物。
[3] 前記成分(b)が水溶性アルミニウム塩である、[1]または[2]に記載の液体口腔用組成物。
[4] 前記水溶性アルミニウム塩が、有機酸のアルミニウム塩である、[3]に記載の液体口腔用組成物。
[5] 前記水溶性アルミニウム塩が、乳酸アルミニウム、硫酸アルミニウムカリウム、硫酸アルミニウム、硝酸アルミニウム、塩化アルミニウム、安息香酸アルミニウムおよびアラントインクロルヒドロキシアルミニウムからなる群から選ばれる一種または二種以上である、[3]に記載の液体口腔用組成物。
[6] 前記成分(a)が、グルコン酸銅、硫酸銅、クエン酸銅、銅クロロフィルおよび銅クロロフィリンナトリウムからなる群から選ばれる一種または二種以上である、[1]乃至[5]いずれか一つに記載の液体口腔用組成物。
[7] 当該液体口腔用組成物中の前記成分(a)の含有量に対する前記成分(b)の含有量が、質量比で、0.25以上300以下である、[1]乃至[6]いずれか一つに記載の液体口腔用組成物。
[8] 舌着色抑制剤である、[1]乃至[7]いずれか一つに記載の液体口腔用組成物。
[9] 口腔粘膜着色抑制剤である、[1]乃至[8]いずれか一つに記載の液体口腔用組成物。
[10] 洗口液である、[1]乃至[9]いずれか一つに記載の液体口腔用組成物。
[11] (a)水溶性銅塩、および
(b)着色抑制剤
を含み、
以下の方法で測定される色差ΔE*が10以上である組成物を口腔に適用することを含む、歯着色抑制方法。
(方法)
1.30mLの前記組成物に、タンニン酸の0.8質量%水溶液10mLを添加し、タンニン酸の最終濃度0.2質量%の測定溶液を調製する。
2.前記測定溶液を37℃にて1週間静置する。
3.静置後、室温、3000rpmで10分間遠心分離し、上清を除去して沈殿を回収する。沈殿の色を分光色彩計で測定し、CIE1976L*a*b*表色系で規定される測色値(L2*,a2*,b2*)を得る。
4.0.1質量%グルコン酸銅水溶液を対照として、上記1.~3.の手順でCIE1976L*a*b*表色系で規定される測色値(L1*,a1*,b1*)を得る。
5.以下の式(I)より色差ΔE*を算出する。
ΔE*=((L2*-L1*)2+(a2*-a1*)2+(b2*-b1*)2)1/2 (I)
According to the present invention, the following liquid oral cavity composition and method for suppressing tooth discoloration are provided.
[1] A liquid oral composition comprising (a) a water-soluble copper salt, and (b) a coloring inhibitor,
A liquid oral composition having a color difference ΔE * of 10 or more as measured by the following method.
(Method)
10 mL of a 0.8% by mass aqueous solution of tannic acid is added to 1.30 mL of the liquid oral composition to prepare a measurement solution with a final tannic acid concentration of 0.2% by mass.
2. The measurement solution is allowed to stand at 37°C for one week.
3. After standing still, centrifugation is performed at room temperature and 3000 rpm for 10 minutes, the supernatant is removed, and the precipitate is collected. The color of the precipitate is measured with a spectrocolorimeter to obtain colorimetric values (L2 * , a2 * , b2 * ) defined by the CIE1976L * a * b * color system.
4. Using 0.1% by mass copper gluconate aqueous solution as a control, the above 1. ~3. Obtain colorimetric values (L1 * , a1 * , b1 * ) defined by the CIE1976L * a * b * color system using the following procedure.
5. The color difference ΔE * is calculated using the following formula (I).
ΔE * = ((L2 * - L1 * ) 2 + (a2 * - a1 * ) 2 + (b2 * - b1 * ) 2 ) 1/2 (I)
[2] The liquid oral composition according to [1], which has a pH of 3.5 or more and 8 or less at 25°C.
[3] The liquid oral composition according to [1] or [2], wherein the component (b) is a water-soluble aluminum salt.
[4] The liquid oral composition according to [3], wherein the water-soluble aluminum salt is an aluminum salt of an organic acid.
[5] The water-soluble aluminum salt is one or more selected from the group consisting of aluminum lactate, potassium aluminum sulfate, aluminum sulfate, aluminum nitrate, aluminum chloride, aluminum benzoate, and aluminum allantoin chlorohydroxy. [3 The liquid oral composition described in ].
[6] Any one of [1] to [5], wherein the component (a) is one or more selected from the group consisting of copper gluconate, copper sulfate, copper citrate, copper chlorophyll, and sodium copper chlorophyllin. Liquid oral composition according to one of the above.
[7] The content of the component (b) to the content of the component (a) in the liquid oral composition is 0.25 or more and 300 or less in mass ratio, [1] to [6] Liquid oral composition according to any one of the above.
[8] The liquid oral composition according to any one of [1] to [7], which is a tongue coloring inhibitor.
[9] The liquid oral composition according to any one of [1] to [8], which is an oral mucosa coloring inhibitor.
[10] The liquid oral composition according to any one of [1] to [9], which is a mouthwash.
[11] Contains (a) a water-soluble copper salt, and (b) a coloring inhibitor,
A method for suppressing tooth discoloration, comprising applying to the oral cavity a composition having a color difference ΔE * of 10 or more as measured by the following method.
(Method)
10 mL of a 0.8% by mass aqueous solution of tannic acid is added to 1.30 mL of the above composition to prepare a measurement solution with a final tannic acid concentration of 0.2% by mass.
2. The measurement solution is allowed to stand at 37°C for one week.
3. After standing still, centrifugation is performed at room temperature and 3000 rpm for 10 minutes, the supernatant is removed, and the precipitate is collected. The color of the precipitate is measured with a spectrocolorimeter to obtain colorimetric values (L2 * , a2 * , b2 * ) defined by the CIE1976L * a * b * color system.
4. Using 0.1% by mass copper gluconate aqueous solution as a control, the above 1. ~3. Obtain colorimetric values (L1 * , a1 * , b1 * ) defined by the CIE1976L * a * b * color system using the following procedure.
5. The color difference ΔE * is calculated using the following formula (I).
ΔE * = ((L2 * - L1 * ) 2 + (a2 * - a1 * ) 2 + (b2 * - b1 * ) 2 ) 1/2 (I)
なお、これらの各構成の任意の組み合わせや、本発明の表現を方法、装置などの間で変換したものもまた本発明の態様として有効である。 Note that arbitrary combinations of these configurations and expressions of the present invention converted between methods, devices, etc. are also effective as aspects of the present invention.
本発明によれば、水溶性銅塩が含まれる液体口腔用組成物を適用する際の口腔内の着色を抑制することができる。 According to the present invention, it is possible to suppress discoloration in the oral cavity when applying a liquid oral composition containing a water-soluble copper salt.
以下、本発明の実施形態について説明する。本実施形態において、組成物は、各成分をいずれも単独でまたは2種以上を組み合わせて含むことができる。
本明細書において、数値範囲を示す「~」は、以上、以下を表し、両端の数値をいずれも含む。
Embodiments of the present invention will be described below. In this embodiment, the composition may contain each component alone or in combination of two or more.
In this specification, "~" indicating a numerical range represents the above or below, and includes both ends of the numerical value.
(液体口腔用組成物)
本実施形態において、液体口腔用組成物は、以下の成分(a)および(b)を含む。
(a)水溶性銅塩
(b)着色抑制剤
そして、以下の方法で測定される液体口腔用組成物の色差ΔE*が10以上である。
(方法)
1.30mLの液体口腔用組成物に、タンニン酸の0.8質量%水溶液10mLを添加し、タンニン酸の最終濃度0.2質量%の測定溶液を調製する。
2.測定溶液を37℃にて1週間静置する。
3.静置後、室温、3000rpmで10分間遠心分離し、上清を除去して沈殿を回収する。沈殿の色を分光色彩計(具体的には、SE7700、日本電色工業社製)で測定し、CIE1976L*a*b*表色系で規定される測色値(L2*,a2*,b2*)を得る。
4.0.1質量%グルコン酸銅水溶液を対照として、上記1.~3.の手順でCIE1976L*a*b*表色系で規定される測色値(L1*,a1*,b1*)を得る。
5.以下の式(I)より色差ΔE*を算出する。
ΔE*=((L2*-L1*)2+(a2*-a1*)2+(b2*-b1*)2)1/2 (I)
ここで、上記手順3.および4.における測色値は、具体的にはD65光源下で測定される。
(Liquid oral composition)
In this embodiment, the liquid oral composition contains the following components (a) and (b).
(a) Water-soluble copper salt (b) Coloration inhibitor The liquid oral composition has a color difference ΔE * of 10 or more as measured by the following method.
(Method)
10 mL of a 0.8% by mass aqueous solution of tannic acid is added to 1.30 mL of the liquid oral composition to prepare a measurement solution with a final tannic acid concentration of 0.2% by mass.
2. The measurement solution is allowed to stand at 37°C for one week.
3. After standing still, centrifugation is performed at room temperature and 3000 rpm for 10 minutes, the supernatant is removed, and the precipitate is collected. The color of the precipitate was measured with a spectrocolorimeter (specifically, SE7700, manufactured by Nippon Denshoku Kogyo Co., Ltd.), and the colorimetric values specified by the CIE1976L * a * b * color system (L2 * , a2 * , b2 * ) get.
4. Using 0.1% by mass copper gluconate aqueous solution as a control, the above 1. ~3. Obtain colorimetric values (L1 * , a1 * , b1 * ) defined by the CIE1976L * a * b * color system using the following procedure.
5. The color difference ΔE * is calculated using the following formula (I).
ΔE * = ((L2 * - L1 * ) 2 + (a2 * - a1 * ) 2 + (b2 * - b1 * ) 2 ) 1/2 (I)
Here, step 3 above. and 4. Specifically, the colorimetric values in are measured under a D65 light source.
本発明者は、液体口腔用組成物が成分(a)および(b)を含むとともに、液体口腔用組成物の色特性、具体的には上記式(I)により算出される色差ΔE*を制御することにより、水溶性銅塩と口腔内に存在する成分とによる着色を効果的に抑制できることを新たに見出した。具体的には、本発明者の検討により、液体口腔用組成物および特定の基準液の加速試験後の測色値より得られるΔE*が口腔内への着色の指標として好適であること、ならびに、基準液に対するΔE*が特定の範囲とすることにより口腔内の着色抑制効果に優れる液体口腔用組成物が得られることが明らかになった。 The present inventor has determined that the liquid oral composition contains components (a) and (b), and also controls the color characteristics of the liquid oral composition, specifically, the color difference ΔE * calculated by the above formula (I). We have newly discovered that by doing so, it is possible to effectively suppress coloring caused by water-soluble copper salts and components present in the oral cavity. Specifically, the present inventors have found that ΔE * obtained from colorimetric values after accelerated testing of liquid oral compositions and specific reference solutions is suitable as an indicator of coloring in the oral cavity; It has been revealed that a liquid oral cavity composition having an excellent effect of suppressing intraoral coloration can be obtained by setting ΔE * in a specific range relative to a reference liquid.
上記式(I)により算出される液体口腔用組成物の測色値ΔE*は、液体口腔用組成物を口腔内に適用する際の着色抑制効果を向上する観点から、10以上であり、好ましくは12以上、より好ましくは15以上、さらに好ましくは20以上である。
また、ΔE*が大きすぎる場合、別系統の色味になるため着色の原因が不明確になる観点から、上記式(I)により算出される液体口腔用組成物の測色値ΔE*は、たとえば100以下であり、好ましくは90以下、より好ましくは80以下、さらに好ましくは70以下である。
The colorimetric value ΔE * of the liquid oral composition calculated by the above formula (I) is preferably 10 or more, from the viewpoint of improving the coloring suppression effect when applying the liquid oral composition to the oral cavity. is 12 or more, more preferably 15 or more, even more preferably 20 or more.
In addition, if ΔE * is too large, the color will be of a different type, making the cause of the coloring unclear. Therefore, the colorimetric value ΔE * of the liquid oral composition calculated by the above formula (I) is as follows: For example, it is 100 or less, preferably 90 or less, more preferably 80 or less, still more preferably 70 or less.
また、上述の手順3.および4.で得られる測色値より、下記式にて液体口腔用組成物のΔL*、Δa*およびΔb*が求められる。
ΔL*=(L2*-L1*)2
Δa*=(a2*-a1*)2
Δb*=(b2*-b1*)2
Also, step 3 above. and 4. From the colorimetric values obtained, ΔL * , Δa * , and Δb * of the liquid oral composition can be determined using the following formula.
ΔL * = (L2 * - L1 * ) 2
Δa * = (a2 * - a1 * ) 2
Δb * = (b2 * - b1 * ) 2
液体口腔用組成物のΔL*は、着色抑制効果向上の観点から、好ましくは10以上であり、より好ましくは20以上、さらに好ましくは30以上である。
また、同様の観点から、液体口腔用組成物のΔL*は、好ましくは80以下であり、より好ましくは70以下、さらに好ましくは60以下である。
The ΔL * of the liquid oral cavity composition is preferably 10 or more, more preferably 20 or more, and even more preferably 30 or more, from the viewpoint of improving the coloration suppressing effect.
Further, from the same viewpoint, ΔL * of the liquid oral cavity composition is preferably 80 or less, more preferably 70 or less, still more preferably 60 or less.
液体口腔用組成物のΔa*は、着色抑制効果向上の観点から、たとえば0.05以上であってよく、好ましくは0.1以上である。
また、着色抑制効果向上の観点から、液体口腔用組成物のΔa*は、好ましくは10以下であり、より好ましくは7以下、さらに好ましくは4以下である。
The Δa * of the liquid oral cavity composition may be, for example, 0.05 or more, and preferably 0.1 or more, from the viewpoint of improving the coloration suppressing effect.
In addition, from the viewpoint of improving the effect of suppressing coloration, the Δa * of the liquid oral cavity composition is preferably 10 or less, more preferably 7 or less, and still more preferably 4 or less.
液体口腔用組成物のΔb*は、着色抑制効果向上の観点から、好ましくは-20以上であり、より好ましくは-15以上、さらに好ましくは-10以上である。
また、着色抑制効果向上の観点から、液体口腔用組成物のΔb*は、好ましくは10以下であり、より好ましくは4以下、さらに好ましくは3以下である。
The Δb * of the liquid oral cavity composition is preferably -20 or more, more preferably -15 or more, and still more preferably -10 or more from the viewpoint of improving the coloration suppressing effect.
Further, from the viewpoint of improving the coloration suppressing effect, the Δb * of the liquid oral cavity composition is preferably 10 or less, more preferably 4 or less, and even more preferably 3 or less.
液体口腔用組成物の室温(25℃、以下同じ。)におけるpHは、歯の脱灰を抑制する観点から、好ましくは3.5以上であり、より好ましくは4.0以上であり、また、たとえば4.5以上、または5以上、または5.5以上であることも好ましい。
また、着色抑制効果向上の観点から、液体口腔用組成物の室温におけるpHは、好ましくは8以下であり、より好ましくは7.5以下、さらに好ましくは7以下である。
The pH of the liquid oral composition at room temperature (25° C., the same applies hereinafter) is preferably 3.5 or higher, more preferably 4.0 or higher, from the viewpoint of suppressing tooth demineralization, and For example, it is also preferably 4.5 or more, or 5 or more, or 5.5 or more.
In addition, from the viewpoint of improving the effect of suppressing coloration, the pH of the liquid oral cavity composition at room temperature is preferably 8 or less, more preferably 7.5 or less, and still more preferably 7 or less.
次に、液体口腔用組成物に含まれる成分について説明する。 Next, the components contained in the liquid oral composition will be explained.
(成分(a))
成分(a)は、水溶性銅塩であり、具体的には、銅の無機酸塩や銅の有機酸塩のうち、水溶性のものをいう。水溶性銅塩は、無水物および水和物のいずれであってもよい。成分(a)は、たとえば医薬品・食品・化粧品原料に用いられるものであればよい。
また、成分(a)として、たとえば、グルコン酸銅、硫酸銅、クエン酸銅、銅クロロフィルおよび銅クロロフィリンナトリウムからなる群から選ばれる一種または二種以上である。口臭抑制効果等の水溶性銅塩の配合効果をより向上する観点から、水溶性銅塩は好ましくはグルコン酸銅、硫酸銅を含み、より好ましくはグルコン酸銅である。
成分(a)としては、たとえば市販品を用いることができる。
(Component (a))
Component (a) is a water-soluble copper salt, and specifically refers to a water-soluble one among inorganic acid salts of copper and organic acid salts of copper. The water-soluble copper salt may be either anhydrous or hydrated. Component (a) may be anything that is used, for example, as a raw material for pharmaceuticals, foods, and cosmetics.
In addition, the component (a) is, for example, one or more selected from the group consisting of copper gluconate, copper sulfate, copper citrate, copper chlorophyll, and sodium copper chlorophyllin. From the viewpoint of further improving the mixing effect of the water-soluble copper salt, such as the halitosis suppressing effect, the water-soluble copper salt preferably contains copper gluconate and copper sulfate, and more preferably copper gluconate.
As component (a), for example, commercially available products can be used.
液体口腔用組成物中の成分(a)の含有量は、口臭抑制効果等の水溶性銅塩の配合効果をより向上する観点から、液体口腔用組成物全体に対し、好ましくは0.001質量%以上であり、より好ましくは0.01質量%以上、さらに好ましくは0.03質量%以上、より好ましくは0.08質量%以上である。
また、口腔内の着色抑制効果向上の観点から、液体口腔用組成物中の成分(a)の含有量は、液体口腔用組成物全体に対し、好ましくは10質量%以下であり、より好ましくは1質量%以下、さらに好ましくは0.5質量%以下、さらにより好ましくは0.3質量%以下、よりいっそう好ましくは0.2質量%以下である。
The content of component (a) in the liquid oral composition is preferably 0.001 mass based on the entire liquid oral composition from the viewpoint of further improving the blending effect of the water-soluble copper salt such as the halitosis suppressing effect. % or more, more preferably 0.01% by mass or more, still more preferably 0.03% by mass or more, even more preferably 0.08% by mass or more.
In addition, from the viewpoint of improving the effect of suppressing coloring in the oral cavity, the content of component (a) in the liquid oral composition is preferably 10% by mass or less, more preferably The content is 1% by mass or less, more preferably 0.5% by mass or less, even more preferably 0.3% by mass or less, even more preferably 0.2% by mass or less.
また、液体口腔用組成物中の成分(a)の含有量は、口臭抑制効果等の水溶性銅塩の配合効果をより向上する観点から、銅の配合量として、好ましくは0.001質量%以上であり、より好ましくは0.003質量%以上であり、また、たとえば0.01質量%以上であってもよい。
また、口腔内の着色抑制効果向上の観点から、液体口腔用組成物中の成分(a)の含有量は、銅の配合量として、好ましくは0.08質量%以下であり、より好ましくは0.06質量%以下であり、また、たとえば0.03質量%以下であってもよい。
In addition, the content of component (a) in the liquid oral composition is preferably 0.001% by mass as the amount of copper blended from the viewpoint of further improving the blending effect of the water-soluble copper salt such as the halitosis suppressing effect. The content is more preferably 0.003% by mass or more, and may be, for example, 0.01% by mass or more.
In addition, from the viewpoint of improving the effect of suppressing coloring in the oral cavity, the content of component (a) in the liquid oral composition is preferably 0.08% by mass or less, more preferably 0.08% by mass or less, as the amount of copper blended. It is not more than .06% by mass, and may be, for example, not more than 0.03% by mass.
(成分(b))
成分(b)は、着色抑制剤である。
成分(b)の具体例として、水溶性アルミニウム塩が挙げられる。
(Component (b))
Component (b) is a coloring inhibitor.
Specific examples of component (b) include water-soluble aluminum salts.
成分(b)は、口腔内の着色抑制効果をより安定的に得る観点から、成分(b)は、好ましくは水溶性アルミニウム塩である。
水溶性アルミニウム塩は、具体的には、アルミニウムの無機酸塩やアルミニウムの有機酸塩のうち、水溶性のものをいう。水溶性アルミニウム塩は、たとえば医薬品・食品・化粧品原料に用いられるものであればよい。
Component (b) is preferably a water-soluble aluminum salt from the viewpoint of more stably obtaining the effect of suppressing coloration in the oral cavity.
Specifically, the water-soluble aluminum salt refers to a water-soluble one among inorganic acid salts of aluminum and organic acid salts of aluminum. Any water-soluble aluminum salt may be used as long as it is used, for example, as a raw material for pharmaceuticals, foods, and cosmetics.
口腔内の着色をより安定的に抑制する観点から、水溶性アルミニウム塩は、好ましくは、乳酸アルミニウム、硫酸アルミニウムカリウム、硫酸アルミニウム、硝酸アルミニウム、塩化アルミニウム、安息香酸アルミニウムおよびアラントインクロルヒドロキシアルミニウムからなる群から選ばれる一種または二種以上である。 From the viewpoint of more stably suppressing intraoral coloration, the water-soluble aluminum salt is preferably a group consisting of aluminum lactate, aluminum potassium sulfate, aluminum sulfate, aluminum nitrate, aluminum chloride, aluminum benzoate, and allantoin chlorohydroxy aluminum. One or more types selected from.
口腔内の着色をより安定的に抑制する観点から、水溶性アルミニウム塩は、好ましくは有機酸のアルミニウム塩である。
有機酸のアルミニウム塩は、たとえば、乳酸アルミニウム、クエン酸アルミニウムおよび安息香酸アルミニウムからなる群から選ばれる一種または二種以上であり、好ましくは乳酸アルミニウムである。
From the viewpoint of more stably suppressing coloring in the oral cavity, the water-soluble aluminum salt is preferably an aluminum salt of an organic acid.
The aluminum salt of an organic acid is, for example, one or more selected from the group consisting of aluminum lactate, aluminum citrate, and aluminum benzoate, and preferably aluminum lactate.
液体口腔用組成物中の水溶性アルミニウム塩の含有量は、口腔内の着色抑制効果向上の観点から、液体口腔用組成物全体に対し、好ましくは0.01質量%以上であり、より好ましくは0.03質量%以上、さらに好ましくは0.06質量%以上、さらにより好ましくは0.1質量%以上、よりいっそう好ましくは0.15質量%以上である。
また、着色抑制効果向上および金属味抑制の観点から、液体口腔用組成物中の水溶性アルミニウム塩の含有量は、液体口腔用組成物全体に対し、好ましくは5質量%以下であり、より好ましくは3.5質量%以下、さらに好ましくは3質量%以下、さらにより好ましくは1.5質量%以下、よりいっそう好ましくは1質量%以下である。
The content of the water-soluble aluminum salt in the liquid oral composition is preferably 0.01% by mass or more, more preferably The content is 0.03% by mass or more, more preferably 0.06% by mass or more, even more preferably 0.1% by mass or more, even more preferably 0.15% by mass or more.
In addition, from the viewpoint of improving the effect of suppressing coloring and suppressing the metallic taste, the content of the water-soluble aluminum salt in the liquid oral composition is preferably 5% by mass or less, more preferably 5% by mass or less, based on the entire liquid oral composition. is 3.5% by mass or less, more preferably 3% by mass or less, even more preferably 1.5% by mass or less, even more preferably 1% by mass or less.
また、液体口腔用組成物中の水溶性アルミニウム塩の含有量は、口腔内の着色抑制効果向上の観点から、アルミニウムの配合量として、好ましくは0.002質量%以上であり、より好ましくは0.005質量%以上である。
また、着色抑制効果向上および金属味抑制の観点から、液体口腔用組成物中の水溶性アルミニウム塩の含有量は、アルミニウムの配合量として、たとえば1質量%以下であってもよく、好ましくは0.5質量%以下であり、より好ましくは0.2質量%以下である。
In addition, the content of water-soluble aluminum salt in the liquid oral composition is preferably 0.002% by mass or more, more preferably 0.002% by mass or more, based on the aluminum content, from the viewpoint of improving the effect of suppressing coloring in the oral cavity. It is .005% by mass or more.
In addition, from the viewpoint of improving the effect of suppressing coloring and suppressing the metallic taste, the content of water-soluble aluminum salt in the liquid oral composition may be, for example, 1% by mass or less, preferably 0. The content is .5% by mass or less, more preferably 0.2% by mass or less.
液体口腔用組成物中の成分(b)の総含有量は、口腔内の着色抑制効果向上の観点から、液体口腔用組成物全体に対し、好ましくは0.01質量%以上であり、より好ましくは0.03質量%以上、さらに好ましくは0.06質量%以上、さらにより好ましくは0.1質量%以上、よりいっそう好ましくは0.15質量%以上である。
また、着色抑制効果向上の観点から、液体口腔用組成物中の成分(b)の総含有量は、液体口腔用組成物全体に対し、好ましくは5質量%以下であり、より好ましくは3.5質量%以下、さらに好ましくは3質量%以下、さらにより好ましくは1.5質量%以下、よりいっそう好ましくは1質量%以下である。
The total content of component (b) in the liquid oral composition is preferably 0.01% by mass or more, more preferably 0.01% by mass or more based on the entire liquid oral composition, from the viewpoint of improving the effect of suppressing coloring in the oral cavity. is 0.03% by mass or more, more preferably 0.06% by mass or more, even more preferably 0.1% by mass or more, even more preferably 0.15% by mass or more.
In addition, from the viewpoint of improving the coloration suppressing effect, the total content of component (b) in the liquid oral composition is preferably 5% by mass or less, more preferably 3.0% by mass or less, based on the entire liquid oral composition. It is 5% by mass or less, more preferably 3% by mass or less, even more preferably 1.5% by mass or less, even more preferably 1% by mass or less.
また、液体口腔用組成物中の成分(a)の含有量に対する成分(a)の含有量(水溶性(b)/(a))は、質量比で、口腔内の着色抑制効果向上の観点から、好ましくは0.25以上であり、より好ましくは0.5以上である。
また、金属味抑制の観点から、上記質量比(水溶性アルミニウム塩/水溶性銅塩)は、好ましくは300以下であり、より好ましくは100以下、さらに好ましくは50以下、さらにより好ましくは20以下、よりいっそう好ましくは5以下である。
In addition, the content of component (a) to the content of component (a) in the liquid oral composition (water solubility (b)/(a)) is a mass ratio, from the viewpoint of improving the effect of suppressing coloring in the oral cavity. Therefore, it is preferably 0.25 or more, more preferably 0.5 or more.
Further, from the viewpoint of suppressing metallic taste, the above mass ratio (water-soluble aluminum salt/water-soluble copper salt) is preferably 300 or less, more preferably 100 or less, still more preferably 50 or less, and even more preferably 20 or less. , more preferably 5 or less.
本実施形態において、好ましくは成分(a)がグルコン酸銅であり、成分(b)が乳酸アルミニウムである。
このとき、グルコン酸銅の含有量は、液体口腔用組成物全体に対して、好ましくは0.01質量%以上0.2質量%以下であり、乳酸アルミニウムの含有量は、液体口腔用組成物全体に対して好ましくは0.01質量%以上3質量%以下である。
In this embodiment, preferably component (a) is copper gluconate and component (b) is aluminum lactate.
At this time, the content of copper gluconate is preferably 0.01% by mass or more and 0.2% by mass or less based on the entire liquid oral composition, and the content of aluminum lactate is preferably 0.01% by mass or more and 0.2% by mass or less with respect to the entire liquid oral composition. It is preferably 0.01% by mass or more and 3% by mass or less based on the whole.
(水)
液体口腔用組成物は、具体的には水を含む。
液体口腔用組成物中の水の含有量は、たとえば液体口腔用組成物中の水以外の成分を除いた残部とすることができる。
(water)
Liquid oral compositions specifically include water.
The content of water in the liquid oral composition can be, for example, the remainder after removing components other than water in the liquid oral composition.
また、液体口腔用組成物中の水の含有量は、液体口腔用組成物全体に対して、好ましくは50質量%以上であり、より好ましくは60質量%以上、さらに好ましくは70質量%以上であり、また、好ましくは99.99質量%以下であり、より好ましくは99.90質量%以下である。 Further, the content of water in the liquid oral composition is preferably 50% by mass or more, more preferably 60% by mass or more, and even more preferably 70% by mass or more, based on the entire liquid oral composition. It is preferably 99.99% by mass or less, more preferably 99.90% by mass or less.
(その他成分)
液体口腔用組成物は、本発明の効果を損なわない範囲で、上述の成分以外の成分を含んでもよい。
かかる成分としては、たとえば、薬用成分、研磨剤、粘結剤、粘稠剤、界面活性剤、矯味剤、防腐剤、香料、着色剤、pH調整剤、溶剤、可溶化剤、基剤、洗浄剤、吸着剤等が挙げられ、剤形に応じて適宜選択し得る。以下に添加成分の具体例を示すが、本発明の配合可能な成分はこれらに限定されるものではない。
(Other ingredients)
The liquid oral composition may contain components other than the above-mentioned components as long as the effects of the present invention are not impaired.
Such components include, for example, medicinal ingredients, abrasives, binders, thickeners, surfactants, flavoring agents, preservatives, fragrances, colorants, pH adjusters, solvents, solubilizers, bases, and detergents. agents, adsorbents, etc., and can be appropriately selected depending on the dosage form. Specific examples of additive components are shown below, but the components that can be blended in the present invention are not limited to these.
薬用成分としては、たとえば、殺菌剤、抗炎症剤、血行促進剤、歯石沈着抑制剤、ステイン除去剤、知覚過敏抑制剤、ビタミン剤および歯垢分解酵素からなる群から選択される一種または二種以上が挙げられる。これらの薬効成分は、医薬品等に使用しうるものであれば限定されない。 Examples of medicinal ingredients include one or two selected from the group consisting of bactericidal agents, anti-inflammatory agents, blood circulation promoters, tartar deposition inhibitors, stain removers, hypersensitivity inhibitors, vitamins, and plaque-degrading enzymes. The above can be mentioned. These medicinal ingredients are not limited as long as they can be used in pharmaceuticals and the like.
薬用成分のうち、殺菌剤としては、たとえば、イソプロピルメチルフェノール、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、ヒノキチオール、クロルヘキシジン塩酸塩、塩酸アルキルジアミノエチルグリシン、ラウロイルサルコシンナトリウムおよびトリクロサンからなる群から選択される一種または二種以上が挙げられる。 Among medicinal ingredients, the bactericidal agent is selected from the group consisting of, for example, isopropylmethylphenol, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, hinokitiol, chlorhexidine hydrochloride, alkyldiaminoethylglycine hydrochloride, sodium lauroylsarcosine, and triclosan. One or more types may be mentioned.
抗炎症剤としては、たとえば、β-グリチルレチン酸、グリチルレチン酸、グリチルリチン酸、グリチルリチン酸二アンモニウム、グリチルリチン酸二ナトリウム、グリチルリチン酸三ナトリウム、グリチルリチン酸二カリウム、グリチルリチン酸モノアンモニウム、トラネキサム酸、ε-アミノカプロン酸、アズレンスルホン酸ナトリウム水和物、アラントイン、アラントインジヒドロキシアルミニウム、エピジヒドロコレステリン、ジヒドロコレステロールおよびリゾチーム塩酸塩からなる群から選択される一種または二種以上が挙げられる。 Examples of anti-inflammatory agents include β-glycyrrhetinic acid, glycyrrhetinic acid, glycyrrhizic acid, diammonium glycyrrhizinate, disodium glycyrrhizinate, trisodium glycyrrhizinate, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, tranexamic acid, and ε-aminocapron. Examples include one or more selected from the group consisting of acid, sodium azulene sulfonate hydrate, allantoin, allantoin dihydroxyaluminum, epidihydrocholesterin, dihydrocholesterol, and lysozyme hydrochloride.
血行促進剤としては、たとえば、塩化ナトリウムが挙げられる。 Examples of blood circulation promoters include sodium chloride.
歯石沈着抑制剤としては、たとえば、ゼオライト、リン酸水素二ナトリウム、ピロリン酸二水素二ナトリウム、ピロリン酸ナトリウム、無水ピロリン酸ナトリウム、ピロリン酸四ナトリウム(無水)、リン酸一水素二ナトリウム、リン酸水素ナトリウム水和物、リン酸水素二ナトリウム(結晶)、リン酸三ナトリウムおよびポリリン酸ナトリウムからなる群から選択される一種または二種以上が挙げられる。 Examples of tartar deposition inhibitors include zeolite, disodium hydrogen phosphate, disodium dihydrogen pyrophosphate, sodium pyrophosphate, anhydrous sodium pyrophosphate, tetrasodium pyrophosphate (anhydrous), disodium monohydrogen phosphate, and phosphoric acid. Examples include one or more selected from the group consisting of sodium hydrogen hydrate, disodium hydrogen phosphate (crystal), trisodium phosphate, and sodium polyphosphate.
ステイン除去剤としては、たとえば、マクロゴール(マクロゴール200、マクロゴール300、マクロゴール400、マクロゴール600、マクロゴール1000、マクロゴール1500、マクロゴール1540、マクロゴール4000、マクロゴール6000、マクロゴール20000など)、ポリリン酸ナトリウムおよびポリビニルピロリドンからなる群から選択される一種または二種以上が挙げられる。 Examples of the stain remover include Macrogol (Macrogol 200, Macrogol 300, Macrogol 400, Macrogol 600, Macrogol 1000, Macrogol 1500, Macrogol 1540, Macrogol 4000, Macrogol 6000, Macrogol 20000). etc.), sodium polyphosphate, and polyvinylpyrrolidone.
知覚過敏抑制剤としては、たとえば、硝酸カリウムおよび水溶性アルミニウム塩以外のアルミニウム塩からなる群から選択される少なくとも一種が挙げられる。 Examples of the hypersensitivity suppressant include at least one selected from the group consisting of potassium nitrate and aluminum salts other than water-soluble aluminum salts.
ビタミン剤としては、たとえば、アスコルビン酸、L-アスコルビン酸、アスコルビン酸ナトリウム、L-アスコルビン酸ナトリウム、ピリドキシン塩酸塩、酢酸DL-α-トコフェロール、トコフェロール酢酸エステル、ニコチン酸dl-α-トコフェロールおよびトコフェロールニコチン酸エステルからなる群から選択される一種または二種以上が挙げられる。 Examples of vitamin preparations include ascorbic acid, L-ascorbic acid, sodium ascorbate, sodium L-ascorbate, pyridoxine hydrochloride, DL-α-tocopherol acetate, tocopherol acetate, dl-α-tocopherol nicotinate, and tocopherol nicotine. One or more types selected from the group consisting of acid esters can be mentioned.
歯垢分解酵素としては、たとえばデキストラナーゼが挙げられる。 Examples of plaque-degrading enzymes include dextranase.
研磨剤としては、たとえば、無水ケイ酸、シリカ(結晶性シリカ又は非晶性シリカ)、シリカゲル、アルミノシリケート等のシリカ系研磨剤;ゼオライト、リン酸水素カルシウム無水和物、リン酸水素カルシウム2水和物、ピロリン酸カルシウム、炭酸カルシウム、水酸化アルミニウム、アルミナ、炭酸マグネシウム、第3リン酸マグネシウム、ケイ酸ジルコニウム、第3リン酸カルシウム、ハイドロキシアパタイト、第4リン酸カルシウムおよび合成樹脂系研磨剤からなる群から選択される一種または二種以上が挙げられる。 Examples of abrasives include silica-based abrasives such as silicic anhydride, silica (crystalline silica or amorphous silica), silica gel, and aluminosilicate; zeolite, calcium hydrogen phosphate anhydrate, and calcium hydrogen phosphate dihydrate. selected from the group consisting of calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, tribasic magnesium phosphate, zirconium silicate, tribasic calcium phosphate, hydroxyapatite, quaternary calcium phosphate, and synthetic resin-based abrasives. One or more types may be mentioned.
粘結剤としては、たとえば、プルラン、ゼラチン、メチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム、カラギーナン、アルギン酸ナトリウム、キサンタンガム、ポリアクリル酸ナトリウム、アラビアガム、グアーガム、ローカストビーンガム、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー等の有機系粘結剤、増粘性無水ケイ酸およびベントナイトからなる群から選択される一種または二種以上が挙げられる。 Examples of binders include pullulan, gelatin, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, carrageenan, sodium alginate, xanthan gum, sodium polyacrylate, gum arabic, guar gum, locust bean gum, polyvinyl alcohol, polyvinyl Examples include one or more selected from the group consisting of organic binders such as pyrrolidone and carboxyvinyl polymers, thickening silicic anhydride, and bentonite.
粘稠剤としては、医薬品・食品・化粧品原料として市販されているものであればよく、たとえば、多価アルコール、さらに具体的にソルビット、グリセリン、濃グリセリン、エチレングリコール、プロピレングリコール、1,3-ブチレングリコール、プロパンジオール(1,3-プロパンジオール)、ポリエチレングリコール、ポリプロピレングリコール、キシリット、マルチット、ラクチット、トレハロース、ヒアルロン酸ナトリウムおよび加水分解コラーゲンからなる群から選択される一種または二種以上が挙げられる。 The thickening agent may be one that is commercially available as a raw material for pharmaceuticals, foods, and cosmetics, such as polyhydric alcohols, more specifically sorbitol, glycerin, concentrated glycerin, ethylene glycol, propylene glycol, 1,3- Examples include one or more selected from the group consisting of butylene glycol, propanediol (1,3-propanediol), polyethylene glycol, polypropylene glycol, xylit, maltit, lactit, trehalose, sodium hyaluronate, and hydrolyzed collagen. .
界面活性剤としては、具体的には、アニオン界面活性剤、カチオン界面活性剤、ノニオン界面活性剤および両性界面活性剤が挙げられ、好ましくはアニオン界面活性剤、ノニオン界面活性剤および両性界面活性剤からなる群から選択される一種または二種以上である。 Specific examples of the surfactant include anionic surfactants, cationic surfactants, nonionic surfactants, and amphoteric surfactants, and preferably anionic surfactants, nonionic surfactants, and amphoteric surfactants. One or more selected from the group consisting of:
アニオン界面活性剤では、たとえば、N-アシルアミノ酸塩、α-オレフィンスルホン酸塩、N-アシルスルホン酸塩、アルキル硫酸塩(たとえばラウリル硫酸ナトリウム)、および、グリセリン脂肪酸エステルの硫酸塩からなる群から選択される一種または二種以上が挙げられる。
ノニオン界面活性剤では、たとえば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン-ポリオキシプロピレンブロック共重合体、ポリオキシエチレン硬化ヒマシ油、グリセリンエステルのポリオキシエチレンエーテル、ショ糖脂肪酸エステル、アルキロールアミドおよびグリセリン脂肪酸エステルからなる群から選択される一種または二種以上が挙げられる。
両性界面活性剤では、たとえば、アルキルベタイン系界面活性剤、アミンオキサイド系界面活性剤およびイミダゾリニウムベタイン系界面活性剤からなる群から選択される一種または二種以上が挙げられる。その具体例としては、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタインやヤシ油脂肪酸アミドアルキルベタインが挙げられる。
Anionic surfactants include, for example, N-acylamino acid salts, α-olefin sulfonates, N-acyl sulfonates, alkyl sulfates (e.g., sodium lauryl sulfate), and sulfates of glycerin fatty acid esters. One or more selected types may be mentioned.
Examples of nonionic surfactants include polyoxyethylene alkyl ethers, polyoxyethylene-polyoxypropylene block copolymers, polyoxyethylene hydrogenated castor oil, polyoxyethylene ethers of glycerin esters, sucrose fatty acid esters, alkylolamides, and One or more types selected from the group consisting of glycerin fatty acid esters can be mentioned.
Examples of amphoteric surfactants include one or more selected from the group consisting of alkyl betaine surfactants, amine oxide surfactants, and imidazolinium betaine surfactants. Specific examples thereof include 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine and coconut oil fatty acid amide alkyl betaine.
矯味剤としては、たとえば、L-グルタミン酸ナトリウム、サッカリン、サッカリンナトリウム、グリチルリチン酸二ナトリウム、グリチルリチン酸三ナトリウム、ショ糖、ブドウ糖、果糖、乳糖、ハチミツ、アスパルテーム、ステビア、スクラロース、キシリトール、イノシトール、D-ソルビトール、D-マンニトール、アラビトール、ラフィノース、ラクチュロース、ラクチトール、エリスリトール、還元パラチノース、パラチノース、パラチニット、アセスルファムK、マルトース、マルトシルトレハロースまたはマルチトール、ネオヘスペリジンジヒドロカルコン、ペリラルチン、p-メトキシシンナミックアルデヒドおよびソーマチンからなる群から選択される一種または二種以上が挙げられる。 Examples of flavoring agents include monosodium L-glutamate, saccharin, sodium saccharin, disodium glycyrrhizinate, trisodium glycyrrhizinate, sucrose, glucose, fructose, lactose, honey, aspartame, stevia, sucralose, xylitol, inositol, D-sorbitol. , D-mannitol, arabitol, raffinose, lactulose, lactitol, erythritol, reduced palatinose, palatinose, palatinite, acesulfame K, maltose, maltosyltrehalose or maltitol, neohesperidin dihydrochalcone, perillartin, p-methoxycinnamic aldehyde and thaumatin One or more types selected from the group consisting of:
防腐剤としては、たとえば、安息香酸ナトリウム、メチルパラベン、エチルパラベン、ブチルパラベン、イソプロピルパラベン、プロピルパラベン、イソブチルパラベン、ベンジルパラベン等のパラオキシ安息香酸エステル;フェノキシエタノール、エタノール等のアルコール類;ソルビン酸、安息香酸、デヒドロ酢酸、プロピオン酸およびこれらの塩;エチレンジアミン四酢酸塩、ならびに、塩酸アルキルジアミノエチルグリシンからなる群から選択される一種または二種以上が挙げられる。 Examples of preservatives include paraoxybenzoic acid esters such as sodium benzoate, methylparaben, ethylparaben, butylparaben, isopropylparaben, propylparaben, isobutylparaben, and benzylparaben; alcohols such as phenoxyethanol and ethanol; sorbic acid and benzoic acid. , dehydroacetic acid, propionic acid, and salts thereof; ethylenediaminetetraacetate, and alkyldiaminoethylglycine hydrochloride.
香料としては、たとえば、L-メントール、ペパーミント、スペアミント、フルーツ香料およびハッカ油からなる群から選択される一種または二種以上が挙げられる。 Examples of the flavor include one or more selected from the group consisting of L-menthol, peppermint, spearmint, fruit flavor, and peppermint oil.
着色剤としては、たとえば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、クマリンド色素等の天然色素;赤色3号、赤色104号、赤色105号、赤色106号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素;リボフラビン、および、二酸化チタンからなる群から選択される一種または二種以上が挙げられる。 Examples of colorants include natural pigments such as safflower red pigment, gardenia yellow pigment, gardenia blue pigment, perilla pigment, red malt pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, coumarind pigment; A type selected from the group consisting of legal pigments such as Red No. 3, Red No. 104, Red No. 105, Red No. 106, Yellow No. 4, Yellow No. 5, Green No. 3, Blue No. 1; riboflavin, and titanium dioxide. Or two or more types can be mentioned.
pH調整剤としては、たとえば、酢酸、塩酸、硫酸、硝酸、クエン酸、リン酸、リンゴ酸、グルコン酸、マレイン酸、コハク酸、グルタミン酸、ピロリン酸、酒石酸、酢酸水酸化ナトリウム、水酸化カリウム、酢酸ナトリウム、炭酸ナトリウム、クエン酸ナトリウム、クエン酸水素ナトリウム、リン酸、リン酸ナトリウム、リン酸一水素ナトリウム、リン酸二水素ナトリウム、リン酸二水素カリウム等の酸やアルカリ、緩衝剤からなる群から選択される一種または二種以上が挙げられる。 Examples of pH adjusting agents include acetic acid, hydrochloric acid, sulfuric acid, nitric acid, citric acid, phosphoric acid, malic acid, gluconic acid, maleic acid, succinic acid, glutamic acid, pyrophosphoric acid, tartaric acid, sodium acetate hydroxide, potassium hydroxide, A group consisting of acids, alkalis, and buffers such as sodium acetate, sodium carbonate, sodium citrate, sodium hydrogen citrate, phosphoric acid, sodium phosphate, sodium monohydrogen phosphate, sodium dihydrogen phosphate, and potassium dihydrogen phosphate. One or more types selected from the following may be mentioned.
溶剤としては、上述の水の他、たとえば、エタノール、プロパノールなどの低級アルコールが挙げられる。 Examples of the solvent include, in addition to the above-mentioned water, lower alcohols such as ethanol and propanol.
可溶化剤は、水への上記添加剤や薬効成分の溶解を促進させるために添加してもよい。そのような可溶化剤の例として、プロピレングリコール、ジプロピレングリコール、ブチレングリコール、ポリエチレングリコール等の多価アルコール類が挙げられる。 A solubilizer may be added to promote dissolution of the above additives and medicinal ingredients in water. Examples of such solubilizers include polyhydric alcohols such as propylene glycol, dipropylene glycol, butylene glycol, and polyethylene glycol.
基剤としては、たとえば炭酸水素ナトリウムが挙げられる。 Examples of the base include sodium hydrogen carbonate.
洗浄剤としては、たとえばポリリン酸ナトリウムが挙げられる。 Examples of cleaning agents include sodium polyphosphate.
吸着剤としては、たとえばβ-シクロデキストリンが挙げられる。 Examples of adsorbents include β-cyclodextrin.
さらに、上記成分以外にも、本発明の内容を損なわない範囲で、通常、液体口腔用組成物等の口腔用組成物の用途に適した成分も適宜配合することができる。 Furthermore, in addition to the above-mentioned components, components suitable for use in oral compositions such as liquid oral compositions can also be appropriately blended within a range that does not impair the content of the present invention.
(液体製剤)
また、液体口腔用組成物は、具体的には液体製剤である。液体製剤は、具体的には経口投与製剤である。
液体口腔用組成物の具体的態様として、洗口液、液体歯磨および口中清涼剤からなる群から選択される一種が挙げられる。液体口腔用組成物は好ましくは洗口液である。
(liquid preparation)
Moreover, the liquid oral composition is specifically a liquid preparation. Liquid formulations are specifically oral formulations.
Specific embodiments of the liquid oral composition include one selected from the group consisting of mouthwashes, liquid toothpastes, and mouth fresheners. The liquid oral composition is preferably a mouthwash.
(製造方法)
本実施形態において、液体口腔用組成物は、たとえば成分(a)、(b)、水および適宜その他の成分を配合する工程を含む。
(Production method)
In this embodiment, the liquid oral composition includes, for example, a step of blending components (a), (b), water, and other components as appropriate.
ここで、上記式差ΔE*は、例えば、液体口腔用組成物を構成する各成分の種類や配合割合を適切に調整することにより制御することが可能である。
さらに具体的には、本実施形態においては、成分(a)および(b)の種類および量を適切に選択、組み合わせて配合を設計することが重要である。
Here, the above formula difference ΔE * can be controlled, for example, by appropriately adjusting the type and blending ratio of each component constituting the liquid oral composition.
More specifically, in this embodiment, it is important to design a formulation by appropriately selecting and combining the types and amounts of components (a) and (b).
本実施形態において得られる液体口腔用組成物は、成分(a)および(b)を含むとともに、上記ΔE*が特定の範囲にあるため、口腔内に適用した際の着色、たとえば舌、口腔粘膜または歯への着色を効果的に抑制することができる。 The liquid oral composition obtained in this embodiment contains components (a) and (b) and has the above-mentioned ΔE * within a specific range. Alternatively, discoloration of teeth can be effectively suppressed.
本実施形態において得られる液体口腔用組成物は、たとえば舌着色抑制剤、口腔粘膜着色抑制剤または歯着色抑制剤として好適に用いられる。 The liquid oral composition obtained in this embodiment is suitably used as, for example, a tongue coloring inhibitor, an oral mucosa coloring inhibitor, or a tooth coloring inhibitor.
本実施形態において、舌着色抑制方法、口腔粘膜着色抑制方法および歯着色抑制方法は、いずれも、成分(a)および(b)を含み、上記がΔE*が10以上である組成物を口腔に適用することを含む。 In the present embodiment, the method for suppressing tongue discoloration, the method for suppressing oral mucosal discoloration, and the method for suppressing tooth discoloration all involve applying a composition containing components (a) and (b) and having a ΔE * of 10 or more to the oral cavity. Including applying.
以上、本発明の実施形態について述べたが、これらは本発明の例示であり、上記以外の様々な構成を採用することもできる。 Although the embodiments of the present invention have been described above, these are merely examples of the present invention, and various configurations other than those described above may also be adopted.
以下、実施例および比較例を挙げて本実施形態を具体的に説明するが、本実施形態はこれらの実施例に限定されるものではない。 The present embodiment will be specifically described below with reference to Examples and Comparative Examples, but the present embodiment is not limited to these Examples.
(試験例)
(実施例1~4、比較例1~7)
表1に記載の成分を混合して各例の洗口液を調製し、後述の方法で評価した。各表に記載の成分の詳細を以下に示す。
グルコン酸銅:扶桑化学工業社製
乳酸アルミニウム:富士フイルム和光純薬社製
タンニン酸:ナカライテスク社製
(Test example)
(Examples 1 to 4, Comparative Examples 1 to 7)
Mouthwashes for each example were prepared by mixing the components listed in Table 1, and evaluated by the method described below. Details of the components listed in each table are shown below.
Copper gluconate: Fuso Chemical Industry Co., Ltd. Aluminum lactate: Fujifilm Wako Pure Chemical Industries, Ltd. Tannic acid: Nacalai Tesque Co., Ltd.
(色測定)
各例の洗口液30mLに、タンニン酸の0.8質量%水溶液10mLを添加し、タンニン酸の最終濃度が0.2質量%であって、成分(a)および(b)の終濃度が表1に示す濃度である測定溶液を調製した。
得られた測定溶液を37℃にて1週間静置した。
静置後、室温、3000rpmで10分間遠心分離し、上清を除去して沈殿を回収する。沈殿の色を分光色彩計(SE7700、日本電色工業社製)にてD65光源下で測定し、CIE1976L*a*b*表色系で規定される測色値(L2*,a2*,b2*)を得た。
一方、0.1質量%グルコン酸銅水溶液を対照例1として、上記1.~3.の手順でCIE1976L*a*b*表色系で規定される測色値(L1*,a1*,b1*)を得た。
以下の式(I)より色差ΔE*を算出した。
ΔE*=((L2*-L1*)2+(a2*-a1*)2+(b2*-b1*)2)1/2 (I)
測定結果を表1にあわせて示す。
(color measurement)
To 30 mL of the mouthwash of each example, 10 mL of a 0.8% by mass aqueous solution of tannic acid was added, so that the final concentration of tannic acid was 0.2% by mass, and the final concentration of components (a) and (b) was Measurement solutions having the concentrations shown in Table 1 were prepared.
The obtained measurement solution was allowed to stand at 37°C for one week.
After standing still, centrifugation is performed at room temperature and 3000 rpm for 10 minutes, the supernatant is removed, and the precipitate is collected. The color of the precipitate was measured using a spectrophotometer (SE7700, manufactured by Nippon Denshoku Kogyo Co., Ltd.) under a D65 light source, and the colorimetric values specified by the CIE1976L * a * b * color system (L2 * , a2 * , b2 * ) obtained.
On the other hand, 0.1% by mass copper gluconate aqueous solution was used as Control Example 1, and the above 1. ~3. Colorimetric values (L1 * , a1 * , b1 * ) defined by the CIE1976L * a * b * color system were obtained using the following procedure.
The color difference ΔE * was calculated using the following formula (I).
ΔE * = ((L2 * - L1 * ) 2 + (a2 * - a1 * ) 2 + (b2 * - b1 * ) 2 ) 1/2 (I)
The measurement results are also shown in Table 1.
(pH測定)
各例の洗口液の25℃におけるpHをpHメーター(アズワン社製、LAQUAtwin)にて測定した。
測定結果を表1にあわせて示す。
(pH measurement)
The pH of the mouthwash in each example at 25° C. was measured using a pH meter (LAQUAtwin, manufactured by As One Corporation).
The measurement results are also shown in Table 1.
(評価方法)
各例の洗口液30mLに、タンニン酸の0.8質量%水溶液10mLを添加して評価用試料を作製した。得られた試料における沈殿物の色を目視で確認し、対照例1との比較により、以下の基準で評価した。結果を表1にあわせて示す。
-:悪化
±:変化なし
+:改善
(Evaluation method)
Samples for evaluation were prepared by adding 10 mL of a 0.8% by mass aqueous solution of tannic acid to 30 mL of the mouthwash of each example. The color of the precipitate in the obtained sample was visually confirmed, and compared with Control Example 1, it was evaluated based on the following criteria. The results are also shown in Table 1.
-: Deterioration ±: No change +: Improvement
表1より、各実施例においては、洗口液のΔE*が特定の範囲にあるため、タンニン酸と共存した際の着色を好適に抑制することができた。 From Table 1, in each Example, since the ΔE * of the mouthwash was within a specific range, coloring when coexisting with tannic acid could be suitably suppressed.
Claims (11)
(b)着色抑制剤
を含む液体口腔用組成物であって、
以下の方法で測定される色差ΔE*が10以上である、液体口腔用組成物。
(方法)
1.30mLの当該液体口腔用組成物に、タンニン酸の0.8質量%水溶液10mLを添加し、タンニン酸の最終濃度0.2質量%の測定溶液を調製する。
2.前記測定溶液を37℃にて1週間静置する。
3.静置後、室温、3000rpmで10分間遠心分離し、上清を除去して沈殿を回収する。沈殿の色を分光色彩計で測定し、CIE1976L*a*b*表色系で規定される測色値(L2*,a2*,b2*)を得る。
4.0.1質量%グルコン酸銅水溶液を対照として、上記1.~3.の手順でCIE1976L*a*b*表色系で規定される測色値(L1*,a1*,b1*)を得る。
5.以下の式(I)より色差ΔE*を算出する。
ΔE*=((L2*-L1*)2+(a2*-a1*)2+(b2*-b1*)2)1/2 (I) A liquid oral composition comprising (a) a water-soluble copper salt, and (b) a coloring inhibitor,
A liquid oral composition having a color difference ΔE * of 10 or more as measured by the following method.
(Method)
10 mL of a 0.8% by mass aqueous solution of tannic acid is added to 1.30 mL of the liquid oral composition to prepare a measurement solution with a final tannic acid concentration of 0.2% by mass.
2. The measurement solution is allowed to stand at 37°C for one week.
3. After standing still, centrifugation is performed at room temperature and 3000 rpm for 10 minutes, the supernatant is removed, and the precipitate is collected. The color of the precipitate is measured with a spectrocolorimeter to obtain colorimetric values (L2 * , a2 * , b2 * ) defined by the CIE1976L * a * b * color system.
4. Using 0.1% by mass copper gluconate aqueous solution as a control, the above 1. ~3. Obtain colorimetric values (L1 * , a1 * , b1 * ) defined by the CIE1976L * a * b * color system using the following procedure.
5. The color difference ΔE * is calculated using the following formula (I).
ΔE * = ((L2 * - L1 * ) 2 + (a2 * - a1 * ) 2 + (b2 * - b1 * ) 2 ) 1/2 (I)
(b)着色抑制剤
を含み、
以下の方法で測定される色差ΔE*が10以上である組成物を口腔に適用することを含む、歯着色抑制方法。
(方法)
1.30mLの前記組成物に、タンニン酸の0.8質量%水溶液10mLを添加し、タンニン酸の最終濃度0.2質量%の測定溶液を調製する。
2.前記測定溶液を37℃にて1週間静置する。
3.静置後、室温、3000rpmで10分間遠心分離し、上清を除去して沈殿を回収する。沈殿の色を分光色彩計で測定し、CIE1976L*a*b*表色系で規定される測色値(L2*,a2*,b2*)を得る。
4.0.1質量%グルコン酸銅水溶液を対照として、上記1.~3.の手順でCIE1976L*a*b*表色系で規定される測色値(L1*,a1*,b1*)を得る。
5.以下の式(I)より色差ΔE*を算出する。
ΔE*=((L2*-L1*)2+(a2*-a1*)2+(b2*-b1*)2)1/2 (I) (a) a water-soluble copper salt; and (b) a coloring inhibitor;
A method for suppressing tooth discoloration, comprising applying to the oral cavity a composition having a color difference ΔE * of 10 or more as measured by the following method.
(Method)
10 mL of a 0.8% by mass aqueous solution of tannic acid is added to 1.30 mL of the above composition to prepare a measurement solution with a final tannic acid concentration of 0.2% by mass.
2. The measurement solution is allowed to stand at 37°C for one week.
3. After standing still, centrifugation is performed at room temperature and 3000 rpm for 10 minutes, the supernatant is removed, and the precipitate is collected. The color of the precipitate is measured with a spectrocolorimeter to obtain colorimetric values (L2 * , a2 * , b2 * ) defined by the CIE1976L * a * b * color system.
4. Using 0.1% by mass copper gluconate aqueous solution as a control, the above 1. ~3. Obtain colorimetric values (L1 * , a1 * , b1 * ) defined by the CIE1976L * a * b * color system using the following procedure.
5. The color difference ΔE * is calculated using the following formula (I).
ΔE * = ((L2 * - L1 * ) 2 + (a2 * - a1 * ) 2 + (b2 * - b1 * ) 2 ) 1/2 (I)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022115018A JP2024013088A (en) | 2022-07-19 | 2022-07-19 | Liquid composition for oral cavity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022115018A JP2024013088A (en) | 2022-07-19 | 2022-07-19 | Liquid composition for oral cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024013088A true JP2024013088A (en) | 2024-01-31 |
Family
ID=89714450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022115018A Pending JP2024013088A (en) | 2022-07-19 | 2022-07-19 | Liquid composition for oral cavity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2024013088A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11944434B2 (en) | 2008-03-05 | 2024-04-02 | Becton, Dickinson And Company | Capillary action collection device and container assembly |
-
2022
- 2022-07-19 JP JP2022115018A patent/JP2024013088A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11944434B2 (en) | 2008-03-05 | 2024-04-02 | Becton, Dickinson And Company | Capillary action collection device and container assembly |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017281923B2 (en) | Oral care compositions and methods of use | |
KR890002946B1 (en) | Oral hygine compositions | |
US3887701A (en) | Antibacterial oral compositions containing preservative-antioxidants | |
EP3128998B1 (en) | Oral care compositions | |
JP2019052110A (en) | Oral composition | |
JP4261744B2 (en) | Oral composition | |
JP2014505077A (en) | Oral care composition | |
US20210121380A1 (en) | Amino Acid Containing Oral Care Composition for Treating Caries By Reducing Lactic Acid Release in Oral Biofilms | |
JP2024013088A (en) | Liquid composition for oral cavity | |
KR20160112919A (en) | Oral composition for effective prevention of calculus formation | |
AU2016381820B2 (en) | Oral care compositions | |
JP6335637B2 (en) | Dentifrice composition | |
WO2023190849A1 (en) | Liquid composition for oral use | |
US20220031598A1 (en) | Oral Care Compositions Containing Abrasives and Cocamidopropyl Betaine | |
KR102579556B1 (en) | Oral composition | |
JP2000053547A (en) | Composition for oral cavity | |
CN118973543A (en) | Liquid oral composition | |
JP2024159646A (en) | Activity-inhibiting composition | |
JPH07215830A (en) | Composition for oral cavity | |
WO2024177022A1 (en) | Liquid composition for oral use | |
JP3862006B2 (en) | Method for preventing discoloration over time of oral composition and water-soluble polyphosphate-containing oral composition | |
JP2021001152A (en) | Liquid oral composition | |
KR100759518B1 (en) | Oral Composition for suppressing oral malodor | |
JP2021004188A (en) | Oral composition | |
JP2024082897A (en) | Composition containing water-soluble copper salt and bicarbonate |